Search research articles
Contact Us
Filters
Showing results (81-90 of 100) with videos related to
Page
of 10
Sort By:
Current Biology : CB
|
September 21, 2000
INCENP binds the Aurora-related kinase AIRK2 and is required to target it to chromosomes, the central spindle and cleavage furrow
R R Adams, S P Wheatley, A M Gouldsworthy, et al.
Current Oncology (Toronto, Ont.)
|
January 5, 2017
Treatment patterns and survival in patients with <i>ALK-</i>positive non-small-cell lung cancer: a Canadian retrospective study
S Kayaniyil, M Hurry, J Wilson, et al.
Thorax
|
January 26, 2002
Beta2 adrenoceptor promoter polymorphisms: extended haplotypes and functional effects in peripheral blood mononuclear cells
B Lipworth, G H Koppelman, A P Wheatley, et al.
Current Oncology (Toronto, Ont.)
|
March 7, 2018
Standardizing biomarker testing for Canadian patients with advanced lung cancer
B Melosky, N Blais, P Cheema, et al.
BMC Neuroscience
|
August 9, 2014
Sox2 acts as a transcriptional repressor in neural stem cells
Yu-Ru Liu, Zulfiqar A Laghari, Carolina A Novoa, et al.
Cell Biology International
|
July 8, 2008
Endopolyploidy in irradiated p53-deficient tumour cell lines: persistence of cell division activity in giant cells expressing Aurora-B kinase
Jekaterina Erenpreisa, Andrei Ivanov, Sally P Wheatley, et al.
The Journal of Clinical Investigation
|
March 9, 2011
Genomic DNA damage and ATR-Chk1 signaling determine oncolytic adenoviral efficacy in human ovarian cancer cells
Claire M Connell, Atsushi Shibata, Laura A Tookman, et al.
Current Oncology (Toronto, Ont.)
|
July 7, 2017
Physician "out of office" alert: does it work?
M Clemons, A A Joy, J Hilton, et al.
Chromosoma
|
July 17, 2001
Human INCENP colocalizes with the Aurora-B/AIRK2 kinase on chromosomes and is overexpressed in tumour cells
R R Adams, D M Eckley, P Vagnarelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 14, 2009
The strength of female sex as a prognostic factor in small-cell lung cancer: a pooled analysis of chemotherapy trials from the Manchester Lung Group and Medical Research Council Clinical Trials Unit
P Wheatley-Price, C Ma, L F Ashcroft, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 100) with videos related to
Sort By:
Page
of 10
Current Biology : CB
|
September 21, 2000
INCENP binds the Aurora-related kinase AIRK2 and is required to target it to chromosomes, the central spindle and cleavage furrow
R R Adams, S P Wheatley, A M Gouldsworthy, et al.
Current Oncology (Toronto, Ont.)
|
January 5, 2017
Treatment patterns and survival in patients with <i>ALK-</i>positive non-small-cell lung cancer: a Canadian retrospective study
S Kayaniyil, M Hurry, J Wilson, et al.
Thorax
|
January 26, 2002
Beta2 adrenoceptor promoter polymorphisms: extended haplotypes and functional effects in peripheral blood mononuclear cells
B Lipworth, G H Koppelman, A P Wheatley, et al.
Current Oncology (Toronto, Ont.)
|
March 7, 2018
Standardizing biomarker testing for Canadian patients with advanced lung cancer
B Melosky, N Blais, P Cheema, et al.
BMC Neuroscience
|
August 9, 2014
Sox2 acts as a transcriptional repressor in neural stem cells
Yu-Ru Liu, Zulfiqar A Laghari, Carolina A Novoa, et al.
Cell Biology International
|
July 8, 2008
Endopolyploidy in irradiated p53-deficient tumour cell lines: persistence of cell division activity in giant cells expressing Aurora-B kinase
Jekaterina Erenpreisa, Andrei Ivanov, Sally P Wheatley, et al.
The Journal of Clinical Investigation
|
March 9, 2011
Genomic DNA damage and ATR-Chk1 signaling determine oncolytic adenoviral efficacy in human ovarian cancer cells
Claire M Connell, Atsushi Shibata, Laura A Tookman, et al.
Current Oncology (Toronto, Ont.)
|
July 7, 2017
Physician "out of office" alert: does it work?
M Clemons, A A Joy, J Hilton, et al.
Chromosoma
|
July 17, 2001
Human INCENP colocalizes with the Aurora-B/AIRK2 kinase on chromosomes and is overexpressed in tumour cells
R R Adams, D M Eckley, P Vagnarelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 14, 2009
The strength of female sex as a prognostic factor in small-cell lung cancer: a pooled analysis of chemotherapy trials from the Manchester Lung Group and Medical Research Council Clinical Trials Unit
P Wheatley-Price, C Ma, L F Ashcroft, et al.
Page
of 10